UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 83 | |
4 mg | In stock | $ 157 | |
8 mg | In stock | $ 223 | |
20 mg | In stock | $ 441 | |
40 mg | In stock | $ 705 |
Description | UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM). |
Targets&IC50 | G9a:<2.5 nM, GLP:<2.5 nM |
In vitro | UNC0642 (Ki: 3.7±1 nM) is competitive with the peptide substrate and non-competitive with the cofactor SAM. UNC0642 is more than 300-fold selective for G9a and GLP over a broad range of kinases, transporters, GPCRs, and ion channels. UNC0642 exhibits high potency at low cell toxicity, reducing the H3K9me2 mark, and good separation of functional potency in a number of cell lines. |
In vivo | UNC0642 (5 mg/kg, i.p.) results in a plasma Cmax of 947 ng/mL and an AUC of 1265 h·ng/ml. |
Synonyms | UNC 0642, UNC-0642 |
CAS No. | 1481677-78-4 |
Chemical Formula | C29H44F2N6O2 |
Molecular Weight | 546.708 |
Solubility | DMSO: 295 mg/mL), Need ultrasonic and warming |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom